Takeda Pharmaceutical Company Limited (FRA:TKD)

FRA:TKD Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	40,304	40,227	46,820	40,204	47,993	43,582
Market Cap Growth	-0.25%	-14.08%	16.45%	-16.23%	10.12%	-22.89%
Enterprise Value	70,773	70,368	75,247	67,122	83,681	86,256
Last Close Price	25.70	24.56	27.48	22.44	25.53	22.05
PE Ratio	31.53	45.57	21.33	23.57	16.57	116.48
PS Ratio	1.43	1.54	1.68	1.52	1.95	1.57
PB Ratio	0.88	0.90	1.06	0.95	1.20	1.09
P/FCF Ratio	-	12.14	8.08	5.42	6.92	9.50
P/OCF Ratio	-	9.16	6.92	4.83	6.16	7.69
EV/Sales Ratio	2.50	2.69	2.70	2.54	3.40	3.10
EV/EBITDA Ratio	8.72	10.09	8.98	7.65	11.04	11.59
EV/EBIT Ratio	19.43	23.28	17.54	15.09	25.62	34.38
EV/FCF Ratio	12.56	21.23	12.99	9.06	12.07	18.80
Debt / Equity Ratio	0.73	0.75	0.77	0.85	0.98	1.16
Debt / EBITDA Ratio	4.13	4.60	3.86	4.07	5.16	6.21
Debt / FCF Ratio	5.92	10.10	5.81	4.81	5.64	10.07
Asset Turnover	0.31	0.29	0.30	0.27	0.25	0.25
Inventory Turnover	1.31	1.30	1.36	1.40	1.34	1.33
Quick Ratio	0.59	0.50	0.49	0.73	1.00	0.65
Current Ratio	1.31	1.11	0.97	1.21	1.53	1.14
Return on Equity (ROE)	2.94%	2.12%	5.27%	4.24%	7.60%	0.89%
Return on Assets (ROA)	2.51%	2.12%	2.85%	2.88%	2.06%	1.39%
Return on Capital (ROIC)	2.97%	2.57%	3.57%	3.62%	2.59%	1.74%
Return on Capital Employed (ROCE)	4.50%	3.90%	5.40%	5.40%	3.80%	2.80%
Earnings Yield	317.16%	2.20%	4.69%	4.24%	6.04%	0.86%
FCF Yield	1397.91%	8.24%	12.37%	18.44%	14.44%	10.53%
Dividend Yield	469.70%	4.69%	4.54%	5.95%	5.43%	6.90%
Payout Ratio	14509.21%	199.34%	88.14%	123.30%	75.36%	638.73%
Buyback Yield / Dilution	-117.40%	-0.67%	0.46%	-0.23%	-0.47%	-61.98%
Total Shareholder Return	352.30%	4.02%	5.00%	5.71%	4.96%	-55.08%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.